Kevin Rakin

Director at Allyx Therapeutics.

Earliest Form D on file: May 2026

Filed May 11, 2026

Allyx Therapeutics

Oral drug to protect synapses in Alzheimer's

Biotech, New Haven CT

Named, Director.

$26.4M

sold of $30M offered

Network

At Allyx Therapeutics

7 people

Dr. Stephen Bloch
Together on 1 filing
Executive Officer, Director, signed as Chief Executive Officer
Gregory P Ho
Together on 1 filing
Director
Paul Fonteyne
Together on 1 filing
Director
Robert A Bettigole
Together on 1 filing
Director
Stephen Strittmatter
Together on 1 filing
Director
Timothy Siegert
Together on 1 filing
Executive Officer

1 more at Allyx Therapeutics